These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

352 related items for PubMed ID: 22710877

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Enhancement of the effects of gemcitabine against pancreatic cancer by oridonin via the mitochondrial caspase-dependent signaling pathway.
    Liu DL, Bu HQ, Jin HM, Zhao JF, Li Y, Huang H.
    Mol Med Rep; 2014 Dec; 10(6):3027-34. PubMed ID: 25242370
    [Abstract] [Full Text] [Related]

  • 3. Oridonin induces apoptosis in SW1990 pancreatic cancer cells via p53- and caspase-dependent induction of p38 MAPK.
    Bu HQ, Liu DL, Wei WT, Chen L, Huang H, Li Y, Cui JH.
    Oncol Rep; 2014 Feb; 31(2):975-82. PubMed ID: 24297112
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. OSI-027 inhibits pancreatic ductal adenocarcinoma cell proliferation and enhances the therapeutic effect of gemcitabine both in vitro and in vivo.
    Zhi X, Chen W, Xue F, Liang C, Chen BW, Zhou Y, Wen L, Hu L, Shen J, Bai X, Liang T.
    Oncotarget; 2015 Sep 22; 6(28):26230-41. PubMed ID: 26213847
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Targeted nuclear factor-kappaB suppression enhances gemcitabine response in human pancreatic tumor cell line murine xenografts.
    Waters JA, Matos J, Yip-Schneider M, Aguilar-Saavedra JR, Crean CD, Beane JD, Dumas RP, Suvannasankha A, Schmidt CM.
    Surgery; 2015 Oct 22; 158(4):881-8; discussion 888-9. PubMed ID: 26209568
    [Abstract] [Full Text] [Related]

  • 9. Intracellular KRAS-specific antibody enhances the anti-tumor efficacy of gemcitabine in pancreatic cancer by inducing endosomal escape.
    Lee JE, Kang YW, Jung KH, Son MK, Shin SM, Kim JS, Kim SJ, Fang Z, Yan HH, Park JH, Yoon YC, Han B, Cheon MJ, Woo MG, Seo MS, Lim JH, Kim YS, Hong SS.
    Cancer Lett; 2021 Jun 01; 507():97-111. PubMed ID: 33744388
    [Abstract] [Full Text] [Related]

  • 10. Oridonin inhibits BxPC-3 cell growth through cell apoptosis.
    Xu B, Shen W, Liu X, Zhang T, Ren J, Fan Y, Xu J.
    Acta Biochim Biophys Sin (Shanghai); 2015 Mar 01; 47(3):164-73. PubMed ID: 25651847
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Ursolic acid inhibits the growth of human pancreatic cancer and enhances the antitumor potential of gemcitabine in an orthotopic mouse model through suppression of the inflammatory microenvironment.
    Prasad S, Yadav VR, Sung B, Gupta SC, Tyagi AK, Aggarwal BB.
    Oncotarget; 2016 Mar 15; 7(11):13182-96. PubMed ID: 26909608
    [Abstract] [Full Text] [Related]

  • 13. Enhancement of the CXCL12/CXCR4 axis due to acquisition of gemcitabine resistance in pancreatic cancer: effect of CXCR4 antagonists.
    Morimoto M, Matsuo Y, Koide S, Tsuboi K, Shamoto T, Sato T, Saito K, Takahashi H, Takeyama H.
    BMC Cancer; 2016 May 12; 16():305. PubMed ID: 27175473
    [Abstract] [Full Text] [Related]

  • 14. Curcumin potentiates antitumor activity of gemcitabine in an orthotopic model of pancreatic cancer through suppression of proliferation, angiogenesis, and inhibition of nuclear factor-kappaB-regulated gene products.
    Kunnumakkara AB, Guha S, Krishnan S, Diagaradjane P, Gelovani J, Aggarwal BB.
    Cancer Res; 2007 Apr 15; 67(8):3853-61. PubMed ID: 17440100
    [Abstract] [Full Text] [Related]

  • 15. Anticancer effects of oridonin on colon cancer are mediated via BMP7/p38 MAPK/p53 signaling.
    Liu RX, Ma Y, Hu XL, Ren WY, Liao YP, Wang H, Zhu JH, Wu K, He BC, Sun WJ.
    Int J Oncol; 2018 Nov 15; 53(5):2091-2101. PubMed ID: 30132514
    [Abstract] [Full Text] [Related]

  • 16. Synergistic antitumor activity of ZD6474, an inhibitor of vascular endothelial growth factor receptor and epidermal growth factor receptor signaling, with gemcitabine and ionizing radiation against pancreatic cancer.
    Bianco C, Giovannetti E, Ciardiello F, Mey V, Nannizzi S, Tortora G, Troiani T, Pasqualetti F, Eckhardt G, de Liguoro M, Ricciardi S, Del Tacca M, Raben D, Cionini L, Danesi R.
    Clin Cancer Res; 2006 Dec 01; 12(23):7099-107. PubMed ID: 17145834
    [Abstract] [Full Text] [Related]

  • 17. Enhanced effect of gemcitabine by emodin against pancreatic cancer in vivo via cytochrome C-regulated apoptosis.
    Chen H, Wei W, Guo Y, Liu A, Tong H, Wang Z, Tan W, Liu J, Lin S.
    Oncol Rep; 2011 May 01; 25(5):1253-61. PubMed ID: 21305255
    [Abstract] [Full Text] [Related]

  • 18. Molecular evidence for increased antitumor activity of gemcitabine by genistein in vitro and in vivo using an orthotopic model of pancreatic cancer.
    Banerjee S, Zhang Y, Ali S, Bhuiyan M, Wang Z, Chiao PJ, Philip PA, Abbruzzese J, Sarkar FH.
    Cancer Res; 2005 Oct 01; 65(19):9064-72. PubMed ID: 16204081
    [Abstract] [Full Text] [Related]

  • 19. Demethylzeylasteral (ZST93) inhibits cell growth and enhances cell chemosensitivity to gemcitabine in human pancreatic cancer cells via apoptotic and autophagic pathways.
    Wang F, Tian X, Zhang Z, Ma Y, Xie X, Liang J, Yang C, Yang Y.
    Int J Cancer; 2018 May 01; 142(9):1938-1951. PubMed ID: 29238973
    [Abstract] [Full Text] [Related]

  • 20. Gemcitabine potentiates anti-tumor effect of resveratrol on pancreatic cancer via down-regulation of VEGF-B.
    Yang Y, Tian W, Yang L, Zhang Q, Zhu M, Liu Y, Li J, Yang L, Liu J, Shen Y, Qi Z.
    J Cancer Res Clin Oncol; 2021 Jan 01; 147(1):93-103. PubMed ID: 32897433
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.